It raconazole Versus Fluconazole as Earlier Empirical Antifungal Therapy in ICU

HUANG Lei,ZHANG Chi,CHEN Ying-qun

DOI: https://doi.org/10.3870/j.issn.1004-0781.2006.11.022

2006-01-01

Abstract:Objective To compare the efficacy and safety of itraconazole with those of fluconazole as earlier empirical antifungal therapy in ICU. Methods In a randomized,controlled,open trial,40 patients with risk factors of systemic fungal infections and unexplained fever that did not respond to broad-spectrum antibiotic therapy for 3-7 days were randomly divided into itraconazole group(20 patients) and fluconazole group(20 patients).Intravenous itraconazole,200 mg,was administered by infusion every 12 hours for the first 48 hours,followed by 200 mg daily from days 3 to 7.From day 8,oral itraconazole solution,200 mg twice daily,replaced intravenous itraconazole for another 14 days.Fluconazole was infused intravenously at a daily dose of 400 mg for 21 days.Body temperature,fungal infection,drug-related adverse events,and the efficacy were investigated. Results For itraconazole and fluconazole,the overall effective rates were 65.0% and 50.0%,and the adverse reactions rates were 30.0% and 5.0% respectively.But there were no significant differences in the overall effective rates and the adverse reactions rates between two groups.Two patients developed deep fungal infections in fluconazole group during the therapy. Conclusion Nowadays,itraconazole and fluconazole are effective and safe as the first-line drugs in earlier empirical therapy in ICU.However,itraconazole appears better in efficacy.